Entasis Therapeutics Holdings Inc. (ETTX) financial statements (2022 and earlier)

Company profile

Business Address 35 GATEHOUSE DRIVE
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:32,30753,24741,00085,100
Cash and cash equivalents32,30753,24716,03449,360
Short-term investments  24,96235,732
Other undisclosed cash, cash equivalents, and short-term investments  48
Receivables1,2581,8901,2321,706
Prepaid expense5,7544,1604,560 
Other current assets4968352,218 
Other undisclosed current assets  (4)1,986
Total current assets:39,81560,13249,00688,792
Noncurrent Assets
Operating lease, right-of-use asset6041,1411,620
Property, plant and equipment198222345419
Other noncurrent assets303636363
Total noncurrent assets:1,1051,4262,028482
TOTAL ASSETS:40,92061,55851,03489,274
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,3434,1364,6194,097
Accounts payable1,1836601,3041,370
Accrued liabilities4925418251,201
Employee-related liabilities3,6682,9352,4901,526
Debt  506 
Other undisclosed current liabilities4,3654,4292,4312,119
Total current liabilities:9,7088,5657,5566,216
Noncurrent Liabilities
Long-term debt and lease obligation 7041,321 
Operating lease, liability 7041,321
Liabilities, other than long-term debt   175
Deferred rent credit   175
Other undisclosed noncurrent liabilities (704)  
Total noncurrent liabilities: 7041,321175
Total liabilities:9,7089,2698,8776,391
Stockholders' equity
Stockholders' equity attributable to parent31,21252,28942,15782,883
Common stock48371313
Additional paid in capital262,760236,707176,103172,988
Accumulated other comprehensive loss   (9)
Accumulated deficit(231,596)(184,455)(133,959)(90,109)
Total stockholders' equity:31,21252,28942,15782,883
TOTAL LIABILITIES AND EQUITY:40,92061,55851,03489,274

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues  7,0005,000
Gross profit:  7,0005,000
Operating expenses(52,317)(54,231)(53,936)(43,207)
Operating loss:(52,317)(54,231)(46,936)(38,207)
Other undisclosed income from continuing operations before equity method investments, income taxes 3,7353,7635,727
Loss from continuing operations before equity method investments, income taxes:(52,317)(50,496)(43,173)(32,480)
Other undisclosed income from continuing operations before income taxes5,176   
Loss from continuing operations before income taxes:(47,141)(50,496)(43,173)(32,480)
Income tax expense  (677)(472)
Net loss attributable to parent:(47,141)(50,496)(43,850)(32,952)
Undistributed earnings (loss) allocated to participating securities, basic   (9,142)
Net loss available to common stockholders, diluted:(47,141)(50,496)(43,850)(42,094)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(47,141)(50,496)(43,850)(32,952)
Comprehensive loss:(47,141)(50,496)(43,850)(32,952)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  9(9)
Comprehensive loss, net of tax, attributable to parent:(47,141)(50,496)(43,841)(32,961)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: